Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Framing of Numerical Information in Cochrane Summaries

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03442387
Recruitment Status : Completed
First Posted : February 22, 2018
Last Update Posted : February 26, 2018
Sponsor:
Information provided by (Responsible Party):
Ivan Buljan, University of Split, School of Medicine

Brief Summary:
The aim of the study was to conduct three different parallel randomized controlled trials to assess how the different framing of Cochrane summary information (positive vs negative framing of health information) affects affect the perception of the efficacy and intention for use of the described treatment.

Condition or disease Intervention/treatment Phase
Health Literacy Other: Frame of numerical information Not Applicable

Detailed Description:
The aim of the study was to conduct three different parallel randomized controlled trials to assess how the different framing of Cochrane summary information (positive vs negative framing of health information) affects affect the perception of the efficacy and intention for use of the described treatment.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 91 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Other
Official Title: Framing of Numerical Information in Cochrane Summaries: a Randomized Controlled Trial
Actual Study Start Date : January 29, 2018
Actual Primary Completion Date : January 29, 2018
Actual Study Completion Date : January 29, 2018

Arm Intervention/treatment
Experimental: Positive frame
The numerical expressions were presented in a positive way: e.g. treatment was successful for 4 out of 10 persons.
Other: Frame of numerical information
Each group received only one frame of information.

Experimental: Negative frame
The numerical expressions were presented in a negative way: e.g. treatment was unsuccessful for 6 out of 10 persons.
Other: Frame of numerical information
Each group received only one frame of information.




Primary Outcome Measures :
  1. Perception of effectiveness [ Time Frame: Immediately after reading ]
    One item on Likert type scale from 1-10, higher score indicates the higher perceived effectiveness.


Secondary Outcome Measures :
  1. Desire to use the described treatment [ Time Frame: Immediately after reading ]
    One item on Likert type scale from 1-10, higher score indicates the greater desire to use the described treatment.

  2. Desire that treatment is prescribed by family doctor [ Time Frame: Immediately after reading ]
    One item on Likert type scale from 1-10. Higher score indicates the greater desire that treatment is prescribed by family doctor.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • First year medical students

Exclusion Criteria:

  • Those who have failed first year and have to repeat it.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03442387


Locations
Layout table for location information
Croatia
University of Split School of Medicine
Split, Croatia, 21000
Sponsors and Collaborators
University of Split, School of Medicine
Investigators
Layout table for investigator information
Principal Investigator: Ivan Buljan, MPsy University of Split, School of Medicine

Layout table for additonal information
Responsible Party: Ivan Buljan, Research Assistant, University of Split, School of Medicine
ClinicalTrials.gov Identifier: NCT03442387     History of Changes
Other Study ID Numbers: Grant No. IP-2014-09-7672
First Posted: February 22, 2018    Key Record Dates
Last Update Posted: February 26, 2018
Last Verified: February 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: Available upon request from principal investigator.
Supporting Materials: Statistical Analysis Plan (SAP)

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No